Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial

OBJECTIVES: We tested whether complementary use of the somatostatin analogue pasireotide would augment efficacy of aspiration sclerotherapy of hepatic cysts. METHODS: We conducted a double-blind, placebo-controlled trial in patients who underwent aspiration sclerotherapy of a large (>5 cm) sympto...

Descripción completa

Detalles Bibliográficos
Autores principales: Wijnands, Titus F. M., Gevers, Tom J. G., Lantinga, Marten A., te Morsche, René H., Schultze Kool, Leo J., Drenth, Joost P. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Interventional
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938297/
https://www.ncbi.nlm.nih.gov/pubmed/29318424
http://dx.doi.org/10.1007/s00330-017-5205-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5938297/
https://www.ncbi.nlm.nih.gov/pubmed/29318424
http://dx.doi.org/10.1007/s00330-017-5205-1

Ejemplares similares